The conservative view: is it necessary to implant a stent into the dopamine transporter?

Br J Pharmacol. 2015 Oct;172(19):4775-8. doi: 10.1111/bph.12766.

Abstract

This article is a reply to De Felice LJ and Cameron KN (2015). Comments on ‘A quantitative model of amphetamine action on the serotonin transporter’, by Sandtner et al., Br J Pharmacol 171: 1007–1018. Br J Pharmacol 172: this issue, doi: 10.1111/bph.12767, commenting on Sandtner W, Schmid D, Schicker K, Gerstbrein K, Koenig X, Mayer FP, Boehm S, Freissmuth M and Sitte HH (2014). A quantitative model of amphetamine action on the 5-HT transporter. Br J Pharmacol 171: 1007–1018. doi: 10.1111/bph.12520

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Humans
  • Models, Biological*
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*
  • Serotonin / pharmacology*
  • Serotonin Agents / pharmacology*
  • Serotonin Plasma Membrane Transport Proteins / physiology*
  • p-Chloroamphetamine / pharmacology*

Substances

  • Serotonin Agents
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin
  • p-Chloroamphetamine
  • N-Methyl-3,4-methylenedioxyamphetamine